ARCHIVES

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Panel Statement On Access To Cancer Care.

October 6, 2000

House-Senate conferees Decide On $733.5 Million (Plus Training Funds) For NCI In 1976

October 31, 1975

NCI Director Klausner Resigns To Head Institute Begun By AOL Chairman Case.

September 14, 2001

Jane Henney Said Tentative Choice For FDA Commissioner

May 22, 1998

ASC Survey Leads to Strategic Plan Development, Office In Washington

June 9, 1989

Decline In Breast Cancer May Be Related to Drop In HT

March 25, 2011